本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prelude Therapeutics Inc

0.7987
-0.0113-1.40%
盘后0.7703-0.0284-3.56%17:21 EDT
成交量:7.68万
成交额:6.21万
市值:4,405.20万
市盈率:-0.48
高:0.8499
开:0.7939
低:0.7800
收:0.8100
数据加载中...
2024/05/04

SEC问询函

Form CORRESP - Correspondence
2024/05/02

SEC问询函

Form CORRESP - Correspondence
2024/04/10

重要事件披露

Form 8-K - Current report
2024/02/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/20

重要事件披露

Form 8-K - Current report